INTERCONNECTS

Chemical Computing Group, Inc. (CCG) announces today the latest release of the Molecular Operating Environment (MOE), software for computer assisted drug discovery and design. MOE 2005.06 contains new features and developments to its wide range of computational applications, including tools for Bioinformatics, Cheminformatics, High Throughput Discovery, Protein Modeling, and Structure Based Design. Version 2005.06 is the result of CCG's continuing research and development efforts. Some notable features in this release include: • Pharmacophore Elucidation; • Automatic 2D Depiction; • Ligand-Receptor Docking; • Integration with MOPAC, GAMESS and Gaussian Paul Labute, CCG's President and CEO, comments “Life science companies will be able to deliver high-end computational methodology throughout their organizations. Information and ideas can now be shared between biology, medicinal chemistry and computational groups. By allowing researchers from various parts of the organization to interact with each other more easily, research efforts can be optimized. CCG's consistent research and development program has resulted in an improved package that will increase flexibility for scientists. " CCG is a developer and worldwide provider of scientific software and computational applications for Life Sciences. CCG's software platform, Molecular Operating Environment (MOE), combines visualization, simulation, and methodology development into an integrated package. MOE’s collection of built-in applications appeal to a wide audience of users, ranging from computational experts to occasional users. MOE applications are built on the Scientific Vector Language (SVL), a chemistry receptive programming system designed specifically for life science application development. Computational chemists, medicinal chemists and biologists use MOE in pharmaceutical companies, biotechnology companies, and universities worldwide.